Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 8/20 | 0.82 |
| ▸ | TUBB | P07437 | 8/20 | 0.82 |
| ▸ | TUBA3C | P0DPH7 | 8/20 | 0.82 |
| ▸ | TUBA1B | P68363 | 8/20 | 0.82 |
| ▸ | TUBA4A | P68366 | 8/20 | 0.82 |
| ▸ | TUBB4B | P68371 | 8/20 | 0.82 |
| ▸ | TUBB3 | Q13509 | 8/20 | 0.82 |
| ▸ | TUBB2A | Q13885 | 8/20 | 0.82 |
| ▸ | TUBB8 | Q3ZCM7 | 8/20 | 0.82 |
| ▸ | TUBA3E | Q6PEY2 | 8/20 | 0.82 |
| ▸ | TUBA1A | Q71U36 | 8/20 | 0.82 |
| ▸ | TUBA1C | Q9BQE3 | 8/20 | 0.82 |
| ▸ | TUBB6 | Q9BUF5 | 8/20 | 0.82 |
| ▸ | TUBB2B | Q9BVA1 | 8/20 | 0.82 |
| ▸ | TUBB1 | Q9H4B7 | 8/20 | 0.82 |
| ▸ | LMNA | P02545 | 7/20 | 0.82 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.82 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.82 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.82 |
| ▸ | TSHR | P16473 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Parbendazole SCHEMBL259455 | 1.00 | TUBB4A (0.82) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Parbendazole SCHEMBL27363030 | 0.90 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Parbendazole SCHEMBL259456 | 0.90 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL9860002 | 0.88 | TUBB4A (0.63) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL11120640 | 0.84 | TUBB4A (0.59) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL11667404 | 0.81 | LMNA (0.58) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL19191488 | 0.80 | TUBB4A (0.53) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28753130 | 0.80 | TUBB4A (0.91) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL28753124 | 0.80 | TUBB4A (1.00) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29511469 | 0.80 | TUBB4A (0.91) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295787-A1 | PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-09-25 | — | — | US | claimed |
| US-20250161243-A1 | MEF2 TRANSCRIPTIONAL ACTIVATORS TO TREAT NEUROLOGIC CONDITIONS | THE SCRIPPS RESEARCH INSTITUTE | 2025-05-22 | — | — | US | claimed |
| CN-120018779-A | Feed and method for controlling infection of central filarial in mammals | 碗中动物健康公司 | 2025-05-16 | — | — | CN | claimed |
| CN-114436972-B | Pabendazole derivative, and preparation method and application thereof | 山东大学 | 2024-02-13 | — | — | CN | claimed |
| CN-117043161-A | Methods and pharmaceutical compositions for treating diseases | 苏州同力生物医药有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-111208283-B | Synergistic tumor inhibiting composition and application thereof | 中国科学院分子细胞科学卓越创新中心 | 2023-09-26 | — | — | CN | claimed |
| CN-116705193-A | Screening method of repositioning candidate medicine and application thereof | 长沙金域医学检验实验室有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116368384-A | Compounds, targets and pathways for macrophage modulation | 麻省理工学院 | 2023-06-30 | — | — | CN | claimed |
| EP-3021832-B9 | PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2023-03-15 | — | — | EP | claimed |
| CN-114436972-A | Pabendazole derivative and preparation method and application thereof | 山东大学 | 2022-05-06 | — | — | CN | claimed |
| EP-3599855-B1 | DELAYED RELEASE FEED-THROUGH VETERINARY COMPOSITIONS WITH OVICIDAL AND LARVICIDAL ACTIVITY AGAINST SUSCEPTIBLE AND RESISTANT STRAINS OF PARASITES IN RUMINANTS' FECES, USE OF THESE COMPOSITIONS, METHOD FOR DELAYING THE RELEASE OF THESE COMPOSITIONS | Champion USA LLC (US) | 2022-03-02 | — | — | EP | claimed |
| CN-122036637-A | Polymorphs | 先正达农作物保护股份公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4676479-A1 | PARBENDAZOLE FOR USE IN THE TREATMENT OF DEMENTIA | Trustlife Global Inc. (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4676479-A1 | PARBENDAZOLE FOR USE IN THE TREATMENT OF DEMENTIA | Trustlife Global Inc. (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20250295787-A1 | PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| CN-114436972-A | Pabendazole derivative and preparation method and application thereof | 山东大学 | 2022-05-06 | — | — | CN | disclosed |
| CN-114436972-A | Pabendazole derivative and preparation method and application thereof | 山东大学 | 2022-05-06 | — | — | CN | disclosed |
| EP-3615540-B1 | CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES | BAYER AG (DE) | 2022-04-27 | — | — | EP | disclosed |
| EP-3974414-A1 | 5-AMINO SUBSTITUTED PYRAZOLES AND TRIAZOLES AS PESTICIDES | Bayer AG (DE) | 2022-03-30 | — | — | EP | disclosed |
| WO-2022053453-A1 | AZOLE CARBOXAMIDE AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250295787-A1 | PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION | SI, PIM1, PIM3 | TUBB4A 3449/4885TUBB 3183/4885TUBA3C 3130/4885 |
| US-20250161243-A1 | MEF2 TRANSCRIPTIONAL ACTIVATORS TO TREAT NEUROLOGIC CONDITIONS | MEF2D, TEAD2, TEAD1 | TUBB4A 1513/4885TUBB 1530/4885TUBA3C 1958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.